ORCL Oracle | $170.00
+1.3% | 2/10/2025 | Downgraded by | Cantor Fitzgerald | Analyst T. Blakey | Overweight | | Medium | View details for Cantor Fitzgerald rating of Oracle (NYSE:ORCL) on 2/10/2025 |
MELI MercadoLibre | $2,223.35
-1.6% | 2/21/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $2,150.00 -> $3,000.00 | High | View details for Cantor Fitzgerald rating of MercadoLibre (NASDAQ:MELI) on 2/21/2025 |
FIVN Five9 | $41.77
-0.8% | 2/21/2025 | Target Raised by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $46.00 -> $57.00 | High | View details for Cantor Fitzgerald rating of Five9 (NASDAQ:FIVN) on 2/21/2025 |
SABR Sabre | $4.29
-5.1% | 2/21/2025 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Neutral -> Neutral | $4.00 -> $4.00 | High | View details for Cantor Fitzgerald rating of Sabre (NASDAQ:SABR) on 2/21/2025 |
BKNG Booking | $5,049.08
+1.2% | 2/21/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $4,900.00 -> $5,540.00 | High | View details for Cantor Fitzgerald rating of Booking (NASDAQ:BKNG) on 2/21/2025 |
BBIO BridgeBio Pharma | $36.25
-1.6% | 2/21/2025 | Reiterated by | Cantor Fitzgerald | Analyst Josh Schimmer | Overweight -> Overweight | $95.00 -> $95.00 | Low | View details for Cantor Fitzgerald rating of BridgeBio Pharma (NASDAQ:BBIO) on 2/21/2025 |
TVTX Travere Therapeutics | $21.23
-3.4% | 2/21/2025 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | | Medium | View details for Cantor Fitzgerald rating of Travere Therapeutics (NASDAQ:TVTX) on 2/21/2025 |
CERS Cerus | $1.64
-0.6% | 2/21/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $4.00 -> $4.00 | High | View details for Cantor Fitzgerald rating of Cerus (NASDAQ:CERS) on 2/21/2025 |
PRTA Prothena | $15.23
-2.1% | 2/21/2025 | Reiterated by | Cantor Fitzgerald | Analyst Eric Schmidt | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Prothena (NASDAQ:PRTA) on 2/21/2025 |
TRIP Tripadvisor | $15.02
-0.6% | 2/21/2025 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Underweight -> Underweight | $14.00 -> $13.00 | High | View details for Cantor Fitzgerald rating of Tripadvisor (NASDAQ:TRIP) on 2/21/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
NICE NICE | $160.99
+3.6% | 2/21/2025 | Target Lowered by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Neutral | $176.00 -> $161.00 | Low | View details for Cantor Fitzgerald rating of NICE (NASDAQ:NICE) on 2/21/2025 |
RIVN Rivian Automotive | $11.96
-7.8% | 2/21/2025 | Downgraded by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Neutral | $13.00 -> $15.00 | Medium | View details for Cantor Fitzgerald rating of Rivian Automotive (NASDAQ:RIVN) on 2/21/2025 |
KRYS Krystal Biotech | $186.89
-0.5% | 2/20/2025 | Reiterated by | Cantor Fitzgerald | Analyst Josh Schimmer | Overweight -> Overweight | $215.00 | High | View details for Cantor Fitzgerald rating of Krystal Biotech (NASDAQ:KRYS) on 2/20/2025 |
WIX Wix.com | $202.32
+2.1% | 2/20/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $260.00 -> $270.00 | High | View details for Cantor Fitzgerald rating of Wix.com (NASDAQ:WIX) on 2/20/2025 |
ETSY Etsy | $53.24
+3.9% | 2/20/2025 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $46.00 -> $43.00 | Medium | View details for Cantor Fitzgerald rating of Etsy (NASDAQ:ETSY) on 2/20/2025 |
ENVX Enovix | $9.82
-8.4% | 2/20/2025 | Reiterated by | Cantor Fitzgerald | Analyst Derek Soderberg | Overweight -> Overweight | $30.00 -> $30.00 | High | View details for Cantor Fitzgerald rating of Enovix (NASDAQ:ENVX) on 2/20/2025 |
KVYO Klaviyo | $41.61
-0.6% | 2/20/2025 | Target Raised by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight -> Overweight | $47.00 -> $54.00 | High | View details for Cantor Fitzgerald rating of Klaviyo (NYSE:KVYO) on 2/20/2025 |
BMRN BioMarin Pharmaceutical | $69.00
+1.1% | 2/20/2025 | Reiterated by | Cantor Fitzgerald | Analyst Olivia Brayer | Overweight -> Overweight | $90.00 -> $90.00 | High | View details for Cantor Fitzgerald rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 2/20/2025 |
AXSM Axsome Therapeutics | $130.72
-5.1% | 2/19/2025 | Reiterated by | Cantor Fitzgerald | Analyst Charles Duncan | Overweight -> Overweight | $153.00 -> $153.00 | Low | View details for Cantor Fitzgerald rating of Axsome Therapeutics (NASDAQ:AXSM) on 2/19/2025 |
INSM Insmed | $80.03
-1.3% | 2/19/2025 | Reiterated by | Cantor Fitzgerald | Analyst Jennifer Kim | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Insmed (NASDAQ:INSM) on 2/19/2025 |
CRSP CRISPR Therapeutics | $46.57
-2.8% | 2/19/2025 | Reiterated by | Cantor Fitzgerald | Analyst Eric Schmidt | Neutral -> Neutral | | Medium | View details for Cantor Fitzgerald rating of CRISPR Therapeutics (NASDAQ:CRSP) on 2/19/2025 |
CNCK Coincheck Group | $6.02
-4.7% | 2/19/2025 | Initiated by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight | $10.00 | Medium | View details for Cantor Fitzgerald rating of Coincheck Group (NASDAQ:CNCK) on 2/19/2025 |
SUPN Supernus Pharmaceuticals | $32.68
-1.1% | 2/19/2025 | Downgraded by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Neutral | $57.00 -> $36.00 | High | View details for Cantor Fitzgerald rating of Supernus Pharmaceuticals (NASDAQ:SUPN) on 2/19/2025 |
LRCX Lam Research | $83.34
-3.1% | 2/18/2025 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $100.00 -> $100.00 | High | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 2/18/2025 |
WDC Western Digital | $49.02
-28.7% | 2/18/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $95.00 -> $95.00 | High | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 2/18/2025 |
INTC Intel | $24.27
-2.4% | 2/18/2025 | Target Raised by | Cantor Fitzgerald | Analyst Matthew Prisco | Neutral -> Neutral | $22.00 -> $29.00 | High | View details for Cantor Fitzgerald rating of Intel (NASDAQ:INTC) on 2/18/2025 |
PHAT Phathom Pharmaceuticals | $5.34
-5.8% | 2/14/2025 | Initiated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $23.00 | High | View details for Cantor Fitzgerald rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 2/14/2025 |
MKSI MKS Instruments | $99.90
-2.9% | 2/13/2025 | Reiterated by | Cantor Fitzgerald | Analyst M. Prisco | Overweight -> Overweight | $140.00 -> $140.00 | High | View details for Cantor Fitzgerald rating of MKS Instruments (NASDAQ:MKSI) on 2/13/2025 |
KRNT Kornit Digital | $25.66
+2.3% | 2/13/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight -> Overweight | $39.00 -> $39.00 | Low | View details for Cantor Fitzgerald rating of Kornit Digital (NASDAQ:KRNT) on 2/13/2025 |
IREN Iris Energy | $10.16
-6.6% | 2/13/2025 | Reiterated by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight -> Overweight | $23.00 -> $23.00 | High | View details for Cantor Fitzgerald rating of Iris Energy (NASDAQ:IREN) on 2/13/2025 |
THC Tenet Healthcare | $131.55
+1.5% | 2/13/2025 | Reiterated by | Cantor Fitzgerald | Analyst Sarah James | Overweight -> Overweight | $177.00 -> $177.00 | High | View details for Cantor Fitzgerald rating of Tenet Healthcare (NYSE:THC) on 2/13/2025 |
AUR Aurora Innovation | $7.01
-5.7% | 2/13/2025 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Overweight | $10.00 -> $10.00 | High | View details for Cantor Fitzgerald rating of Aurora Innovation (NASDAQ:AUR) on 2/13/2025 |
TTD Trade Desk | $74.20
+3.0% | 2/13/2025 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $115.00 -> $100.00 | High | View details for Cantor Fitzgerald rating of Trade Desk (NASDAQ:TTD) on 2/13/2025 |
GHRS GH Research | $12.21
-2.4% | 2/13/2025 | Initiated by | Cantor Fitzgerald | Analyst Charles Duncan | Overweight | $14.00 | Low | View details for Cantor Fitzgerald rating of GH Research (NASDAQ:GHRS) on 2/13/2025 |
CVS CVS Health | $62.95
-0.8% | 2/12/2025 | Upgraded by | Cantor Fitzgerald | Analyst S. James | Neutral -> Overweight | | High | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 2/12/2025 |
HUM Humana | $255.02
-0.3% | 2/12/2025 | Reiterated by | Cantor Fitzgerald | Analyst Sarah James | Neutral -> Neutral | $290.00 -> $290.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 2/12/2025 |
DASH DoorDash | $195.87
-2.0% | 2/12/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $200.00 -> $230.00 | Medium | View details for Cantor Fitzgerald rating of DoorDash (NASDAQ:DASH) on 2/12/2025 |
ZG Zillow Group | $72.65
+0.8% | 2/12/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $62.00 -> $70.00 | Medium | View details for Cantor Fitzgerald rating of Zillow Group (NASDAQ:ZG) on 2/12/2025 |
LYFT Lyft | $12.72
-2.5% | 2/12/2025 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $15.00 -> $14.00 | High | View details for Cantor Fitzgerald rating of Lyft (NASDAQ:LYFT) on 2/12/2025 |
FRSH Freshworks | $17.20
-0.6% | 2/12/2025 | Target Raised by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight -> Overweight | $18.00 -> $22.00 | High | View details for Cantor Fitzgerald rating of Freshworks (NASDAQ:FRSH) on 2/12/2025 |
Nvidia > DeepSeek (Ad) Everyone's getting it all wrong …
Sure, DeepSeek's reveal caused AI stocks to tumble …
But, in the long run … that's a good thing. Click here to see why Nvidia's bad day could end up being a great year. |
FROG JFrog | $37.95
-1.5% | 2/12/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $38.00 -> $38.00 | High | View details for Cantor Fitzgerald rating of JFrog (NASDAQ:FROG) on 2/12/2025 |
PANW Palo Alto Networks | $190.39
-0.3% | 2/12/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $223.00 -> $223.00 | N/A | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 2/12/2025 |
SHOP Shopify | $115.45
-0.1% | 2/12/2025 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $120.00 -> $120.00 | Low | View details for Cantor Fitzgerald rating of Shopify (NYSE:SHOP) on 2/12/2025 |
ASND Ascendis Pharma A/S | $151.06
-0.9% | 2/11/2025 | Reiterated by | Cantor Fitzgerald | Analyst Li Watsek | Overweight -> Overweight | $170.00 -> $170.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 2/11/2025 |
MNDY monday.com | $298.10
-0.8% | 2/11/2025 | Target Raised by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $292.00 -> $380.00 | Low | View details for Cantor Fitzgerald rating of monday.com (NASDAQ:MNDY) on 2/11/2025 |
VRTX Vertex Pharmaceuticals | $481.65
-0.5% | 2/11/2025 | Reiterated by | Cantor Fitzgerald | Analyst Olivia Brayer | Overweight -> Overweight | $480.00 -> $480.00 | Medium | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 2/11/2025 |
SEPN Septerna | $5.73
-1.2% | 2/11/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | $50.00 -> $50.00 | High | View details for Cantor Fitzgerald rating of Septerna (NASDAQ:SEPN) on 2/11/2025 |
DOMO Domo | $7.90
-3.2% | 2/11/2025 | Initiated by | Cantor Fitzgerald | Analyst Yi Fu Lee | Overweight | $11.00 | Medium | View details for Cantor Fitzgerald rating of Domo (NASDAQ:DOMO) on 2/11/2025 |
WDC Western Digital | $49.02
-28.7% | 2/10/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $95.00 -> $95.00 | High | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 2/10/2025 |
PRLB Proto Labs | $40.29
-0.7% | 2/10/2025 | Target Raised by | Cantor Fitzgerald | Analyst Troy Jensen | Overweight -> Overweight | $40.00 -> $50.00 | Low | View details for Cantor Fitzgerald rating of Proto Labs (NYSE:PRLB) on 2/10/2025 |
SAIC Science Applications International | $98.88
+1.1% | 2/6/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Hold | | Low | View details for Cantor Fitzgerald rating of Science Applications International (NYSE:SAIC) on 2/6/2025 |
LDOS Leidos | $128.43
+1.3% | 2/6/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Leidos (NYSE:LDOS) on 2/6/2025 |
CACI CACI International | $327.27
+0.1% | 2/6/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of CACI International (NYSE:CACI) on 2/6/2025 |
BAH Booz Allen Hamilton | $112.17
-0.1% | 2/6/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Booz Allen Hamilton (NYSE:BAH) on 2/6/2025 |
ARVN Arvinas | $16.75
-5.7% | 2/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst Li Watsek | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Arvinas (NASDAQ:ARVN) on 2/7/2025 |
PINS Pinterest | $36.99
-2.0% | 2/7/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $36.00 -> $48.00 | High | View details for Cantor Fitzgerald rating of Pinterest (NYSE:PINS) on 2/7/2025 |
AMZN Amazon.com | $212.71
-1.8% | 2/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $270.00 -> $270.00 | Low | View details for Cantor Fitzgerald rating of Amazon.com (NASDAQ:AMZN) on 2/7/2025 |
EXPE Expedia Group | $199.97
+1.6% | 2/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $180.00 -> $210.00 | High | View details for Cantor Fitzgerald rating of Expedia Group (NASDAQ:EXPE) on 2/7/2025 |
NET Cloudflare | $147.92
-2.7% | 2/7/2025 | Target Raised by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Neutral | $111.00 -> $149.00 | High | View details for Cantor Fitzgerald rating of Cloudflare (NYSE:NET) on 2/7/2025 |
ONTO Onto Innovation | $158.15
-0.8% | 2/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst M. Prisco | Overweight -> Overweight | $250.00 -> $250.00 | Low | View details for Cantor Fitzgerald rating of Onto Innovation (NYSE:ONTO) on 2/7/2025 |
CACI CACI International | $327.27
+0.1% | 2/7/2025 | Initiated by | Cantor Fitzgerald | - | Overweight | $535.00 | Low | View details for Cantor Fitzgerald rating of CACI International (NYSE:CACI) on 2/7/2025 |
BAH Booz Allen Hamilton | $112.17
-0.1% | 2/7/2025 | Initiated by | Cantor Fitzgerald | - | Overweight | $160.00 | Low | View details for Cantor Fitzgerald rating of Booz Allen Hamilton (NYSE:BAH) on 2/7/2025 |
AMTM Amentum | $19.79
-1.1% | 2/7/2025 | Initiated by | Cantor Fitzgerald | Analyst C. Canfield | Strong-Buy -> Neutral | $25.00 | Medium | View details for Cantor Fitzgerald rating of Amentum (NYSE:AMTM) on 2/7/2025 |
SAIC Science Applications International | $98.88
+1.1% | 2/7/2025 | Initiated by | Cantor Fitzgerald | - | Neutral | $120.00 | Medium | View details for Cantor Fitzgerald rating of Science Applications International (NYSE:SAIC) on 2/7/2025 |
LDOS Leidos | $128.43
+1.3% | 2/7/2025 | Initiated by | Cantor Fitzgerald | - | Overweight | $185.00 | Medium | View details for Cantor Fitzgerald rating of Leidos (NYSE:LDOS) on 2/7/2025 |
MSTR MicroStrategy | $282.76
-5.6% | 2/6/2025 | Target Raised by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $613.00 -> $619.00 | High | View details for Cantor Fitzgerald rating of MicroStrategy (NASDAQ:MSTR) on 2/6/2025 |
PI Impinj | $94.62
-2.2% | 2/6/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Troy Jensen | Overweight -> Overweight | $260.00 -> $133.00 | High | View details for Cantor Fitzgerald rating of Impinj (NASDAQ:PI) on 2/6/2025 |
DT Dynatrace | $59.02
-1.4% | 2/6/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Neutral | $57.00 -> $57.00 | Low | View details for Cantor Fitzgerald rating of Dynatrace (NYSE:DT) on 2/6/2025 |
UBER Uber Technologies | $76.34
-3.2% | 2/6/2025 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $80.00 -> $80.00 | High | View details for Cantor Fitzgerald rating of Uber Technologies (NYSE:UBER) on 2/6/2025 |
QCOM QUALCOMM | $161.10
-2.6% | 2/6/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Neutral -> Neutral | $160.00 -> $160.00 | High | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 2/6/2025 |
CSGS CSG Systems International | $66.14
+3.3% | 2/6/2025 | Target Raised by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight -> Overweight | $64.00 -> $72.00 | High | View details for Cantor Fitzgerald rating of CSG Systems International (NASDAQ:CSGS) on 2/6/2025 |
SYM Symbotic | $24.38
-0.4% | 2/6/2025 | Reiterated by | Cantor Fitzgerald | Analyst Derek Soderberg | Overweight -> Overweight | $60.00 -> $60.00 | High | View details for Cantor Fitzgerald rating of Symbotic (NASDAQ:SYM) on 2/6/2025 |
ASTS AST SpaceMobile | $28.57
-0.2% | 2/6/2025 | Initiated by | Cantor Fitzgerald | Analyst Colin Canfield | Overweight | $30.00 | High | View details for Cantor Fitzgerald rating of AST SpaceMobile (NASDAQ:ASTS) on 2/6/2025 |
ZLAB Zai Lab | $32.95
-2.5% | 2/5/2025 | Upgraded by | Cantor Fitzgerald | Analyst L. Watsek | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Zai Lab (NASDAQ:ZLAB) on 2/5/2025 |
CDTX Cidara Therapeutics | $20.50
-4.8% | 2/5/2025 | Upgraded by | Cantor Fitzgerald | Analyst E. Schmidt | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Cidara Therapeutics (NASDAQ:CDTX) on 2/5/2025 |
CATX Perspective Therapeutics | $2.73
-1.1% | 2/5/2025 | Upgraded by | Cantor Fitzgerald | Analyst L. Watsek | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Perspective Therapeutics (NYSE:CATX) on 2/5/2025 |
CIFR Cipher Mining | $4.97
-9.5% | 2/4/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight -> Overweight | $11.00 -> $10.00 | Low | View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 2/4/2025 |
NXPI NXP Semiconductors | $233.15
-1.4% | 2/4/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $250.00 -> $250.00 | High | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 2/4/2025 |
BMY Bristol-Myers Squibb | $57.83
+3.6% | 2/4/2025 | Target Raised by | Cantor Fitzgerald | Analyst Olivia Brayer | Neutral -> Neutral | $50.00 -> $55.00 | Medium | View details for Cantor Fitzgerald rating of Bristol-Myers Squibb (NYSE:BMY) on 2/4/2025 |
FTNT Fortinet | $108.69
-1.2% | 2/4/2025 | Target Raised by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $95.00 -> $110.00 | Medium | View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 2/4/2025 |
PLTR Palantir Technologies | $90.68
-10.5% | 2/4/2025 | Target Raised by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Neutral | $72.00 -> $98.00 | N/A | View details for Cantor Fitzgerald rating of Palantir Technologies (NASDAQ:PLTR) on 2/4/2025 |
UHS Universal Health Services | $181.21
+0.7% | 2/3/2025 | Upgraded by | Cantor Fitzgerald | Analyst S. James | Neutral -> Overweight | | Low | View details for Cantor Fitzgerald rating of Universal Health Services (NYSE:UHS) on 2/3/2025 |
PTCT PTC Therapeutics | $50.02
-1.3% | 2/3/2025 | Target Raised by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $76.00 -> $113.00 | High | View details for Cantor Fitzgerald rating of PTC Therapeutics (NASDAQ:PTCT) on 2/3/2025 |
SSYS Stratasys | $11.06
-1.2% | 2/3/2025 | Reiterated by | Cantor Fitzgerald | Analyst Troy Jensen | Overweight -> Overweight | $12.00 -> $12.00 | High | View details for Cantor Fitzgerald rating of Stratasys (NASDAQ:SSYS) on 2/3/2025 |
ROIV Roivant Sciences | $10.52
-1.5% | 1/30/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Agrawal | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Roivant Sciences (NASDAQ:ROIV) on 1/30/2025 |
MESO Mesoblast | $16.23
-0.9% | 1/30/2025 | Upgraded by | Cantor Fitzgerald | Analyst K. Kluska | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Mesoblast (NASDAQ:MESO) on 1/30/2025 |
IMVT Immunovant | $20.43
-3.9% | 1/30/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Agrawal | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Immunovant (NASDAQ:IMVT) on 1/30/2025 |
ARDX Ardelyx | $5.13
+1.4% | 1/30/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Agrawal | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Ardelyx (NASDAQ:ARDX) on 1/30/2025 |
ACRS Aclaris Therapeutics | $2.07
-7.6% | 1/30/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Agrawal | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Aclaris Therapeutics (NASDAQ:ACRS) on 1/30/2025 |
KLAC KLA | $737.57
-2.0% | 1/31/2025 | Target Raised by | Cantor Fitzgerald | Analyst Matthew Prisco | Neutral -> Neutral | $800.00 -> $875.00 | High | View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 1/31/2025 |
Nvidia > DeepSeek (Ad) Everyone's getting it all wrong …
Sure, DeepSeek's reveal caused AI stocks to tumble …
But, in the long run … that's a good thing. Click here to see why Nvidia's bad day could end up being a great year. |
INTC Intel | $24.27
-2.4% | 1/31/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Neutral -> Neutral | $22.00 -> $22.00 | High | View details for Cantor Fitzgerald rating of Intel (NASDAQ:INTC) on 1/31/2025 |
VRTX Vertex Pharmaceuticals | $481.65
-0.5% | 1/31/2025 | Reiterated by | Cantor Fitzgerald | Analyst Olivia Brayer | Overweight -> Overweight | $480.00 -> $480.00 | Medium | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 1/31/2025 |
CI The Cigna Group | $300.80
+0.3% | 1/31/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Sarah James | Overweight -> Overweight | $400.00 -> $350.00 | Medium | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 1/31/2025 |
DT Dynatrace | $59.02
-1.4% | 1/31/2025 | Target Lowered by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Neutral | $58.00 -> $57.00 | Low | View details for Cantor Fitzgerald rating of Dynatrace (NYSE:DT) on 1/31/2025 |
ACRV Acrivon Therapeutics | $5.38
-2.9% | 1/31/2025 | Initiated by | Cantor Fitzgerald | Analyst Li Watsek | Overweight | | Low | View details for Cantor Fitzgerald rating of Acrivon Therapeutics (NASDAQ:ACRV) on 1/31/2025 |
TEAM Atlassian | $284.06
-0.7% | 1/31/2025 | Target Raised by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Neutral | $264.00 -> $304.00 | High | View details for Cantor Fitzgerald rating of Atlassian (NASDAQ:TEAM) on 1/31/2025 |
TER Teradyne | $113.58
-2.0% | 1/30/2025 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $160.00 -> $160.00 | High | View details for Cantor Fitzgerald rating of Teradyne (NASDAQ:TER) on 1/30/2025 |
META Meta Platforms | $668.13
-2.3% | 1/30/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $720.00 -> $790.00 | High | View details for Cantor Fitzgerald rating of Meta Platforms (NASDAQ:META) on 1/30/2025 |
WDC Western Digital | $49.02
-28.7% | 1/30/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $95.00 -> $95.00 | High | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 1/30/2025 |
ZVRA Zevra Therapeutics | $7.45
-3.0% | 1/29/2025 | Upgraded by | Cantor Fitzgerald | Analyst K. Kluska | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Zevra Therapeutics (NASDAQ:ZVRA) on 1/29/2025 |
LRCX Lam Research | $83.34
-3.1% | 1/30/2025 | Upgraded by | Cantor Fitzgerald | Analyst Matthew Prisco | Neutral -> Overweight | $95.00 -> $100.00 | High | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 1/30/2025 |
CVLT Commvault Systems | $169.81
-0.5% | 1/29/2025 | Target Raised by | Cantor Fitzgerald | Analyst Thomas Blakey | Neutral -> Neutral | $159.00 -> $173.00 | High | View details for Cantor Fitzgerald rating of Commvault Systems (NASDAQ:CVLT) on 1/29/2025 |
TSLA Tesla | $330.53
-2.2% | 1/29/2025 | Reiterated by | Cantor Fitzgerald | Analyst Andres Sheppard | Neutral -> Neutral | $365.00 -> $365.00 | Medium | View details for Cantor Fitzgerald rating of Tesla (NASDAQ:TSLA) on 1/29/2025 |
CLDX Celldex Therapeutics | $21.33
-5.0% | 1/29/2025 | Reiterated by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $67.00 -> $67.00 | High | View details for Cantor Fitzgerald rating of Celldex Therapeutics (NASDAQ:CLDX) on 1/29/2025 |
MSFT Microsoft | $404.00
-1.0% | 1/29/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $509.00 -> $509.00 | Low | View details for Cantor Fitzgerald rating of Microsoft (NASDAQ:MSFT) on 1/29/2025 |
BKNG Booking | $5,049.08
+1.2% | 1/29/2025 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $5,100.00 -> $4,900.00 | Low | View details for Cantor Fitzgerald rating of Booking (NASDAQ:BKNG) on 1/29/2025 |
EXPE Expedia Group | $199.97
+1.6% | 1/29/2025 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $190.00 -> $180.00 | Low | View details for Cantor Fitzgerald rating of Expedia Group (NASDAQ:EXPE) on 1/29/2025 |
BEAM Beam Therapeutics | $30.79
+1.2% | 1/29/2025 | Upgraded by | Cantor Fitzgerald | Analyst R. Bienkowski | Neutral -> Overweight | | Medium | View details for Cantor Fitzgerald rating of Beam Therapeutics (NASDAQ:BEAM) on 1/29/2025 |
UBER Uber Technologies | $76.34
-3.2% | 1/28/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $75.00 -> $80.00 | Medium | View details for Cantor Fitzgerald rating of Uber Technologies (NYSE:UBER) on 1/28/2025 |
DASH DoorDash | $195.87
-2.0% | 1/28/2025 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $200.00 -> $200.00 | Medium | View details for Cantor Fitzgerald rating of DoorDash (NASDAQ:DASH) on 1/28/2025 |
SPOT Spotify Technology | $601.54
-1.0% | 1/28/2025 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $490.00 -> $480.00 | Medium | View details for Cantor Fitzgerald rating of Spotify Technology (NYSE:SPOT) on 1/28/2025 |
CDTX Cidara Therapeutics | $20.50
-4.8% | 1/27/2025 | Reiterated by | Cantor Fitzgerald | Analyst Eric Schmidt | Overweight | | Medium | View details for Cantor Fitzgerald rating of Cidara Therapeutics (NASDAQ:CDTX) on 1/27/2025 |
CYBR CyberArk Software | $374.73
-2.2% | 1/27/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $415.00 -> $415.00 | High | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 1/27/2025 |
CHKP Check Point Software Technologies | $215.21
-0.7% | 1/27/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $200.00 -> $200.00 | High | View details for Cantor Fitzgerald rating of Check Point Software Technologies (NASDAQ:CHKP) on 1/27/2025 |
NVDA NVIDIA | $130.28
-3.1% | 1/27/2025 | Reiterated by | Cantor Fitzgerald | Analyst C J Muse | Overweight -> Overweight | $200.00 -> $200.00 | High | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 1/27/2025 |
HCA HCA Healthcare | $319.33
+0.9% | 1/27/2025 | Reiterated by | Cantor Fitzgerald | Analyst Sarah James | Overweight -> Overweight | $405.00 -> $405.00 | High | View details for Cantor Fitzgerald rating of HCA Healthcare (NYSE:HCA) on 1/27/2025 |
TXN Texas Instruments | $200.74
-0.6% | 1/24/2025 | Reiterated by | Cantor Fitzgerald | Analyst Jonathan Fiore | Neutral -> Neutral | $200.00 -> $200.00 | High | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 1/24/2025 |
ALXO ALX Oncology | $1.07
-4.5% | 1/24/2025 | Reiterated by | Cantor Fitzgerald | Analyst Li Watsek | Overweight -> Overweight | | Medium | View details for Cantor Fitzgerald rating of ALX Oncology (NASDAQ:ALXO) on 1/24/2025 |
ELV Elevance Health | $384.91
0.0% | 1/24/2025 | Reiterated by | Cantor Fitzgerald | Analyst Sarah James | Overweight -> Overweight | $485.00 -> $485.00 | Low | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 1/24/2025 |
VRTX Vertex Pharmaceuticals | $481.65
-0.5% | 1/24/2025 | Reiterated by | Cantor Fitzgerald | Analyst Olivia Brayer | Overweight -> Overweight | $480.00 -> $480.00 | Low | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 1/24/2025 |
ZLDPF Zealand Pharma A/S | $100.00
-7.7% | 1/21/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Agrawal | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Zealand Pharma A/S (OTCMKTS:ZLDPF) on 1/21/2025 |
RDW Redwire | $16.40
-8.4% | 1/24/2025 | Initiated by | Cantor Fitzgerald | Analyst Colin Canfield | Overweight -> Overweight | $28.00 -> $28.00 | Low | View details for Cantor Fitzgerald rating of Redwire (NYSE:RDW) on 1/24/2025 |
VSAT Viasat | $9.09
+1.0% | 1/24/2025 | Initiated by | Cantor Fitzgerald | Analyst C. Canfield | Neutral | $12.00 | Medium | View details for Cantor Fitzgerald rating of Viasat (NASDAQ:VSAT) on 1/24/2025 |
PL Planet Labs PBC | $4.69
-5.7% | 1/24/2025 | Initiated by | Cantor Fitzgerald | Analyst C. Canfield | Overweight | $6.30 | High | View details for Cantor Fitzgerald rating of Planet Labs PBC (NYSE:PL) on 1/24/2025 |
IRDM Iridium Communications | $31.43
+1.1% | 1/24/2025 | Initiated by | Cantor Fitzgerald | Analyst C. Canfield | Overweight | $40.00 | High | View details for Cantor Fitzgerald rating of Iridium Communications (NASDAQ:IRDM) on 1/24/2025 |
SYM Symbotic | $24.38
-0.4% | 1/23/2025 | Reiterated by | Cantor Fitzgerald | Analyst Derek Soderberg | Overweight -> Overweight | $60.00 -> $60.00 | Low | View details for Cantor Fitzgerald rating of Symbotic (NASDAQ:SYM) on 1/23/2025 |
AMZN Amazon.com | $212.71
-1.8% | 1/22/2025 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $270.00 -> $270.00 | Low | View details for Cantor Fitzgerald rating of Amazon.com (NASDAQ:AMZN) on 1/22/2025 |
STX Seagate Technology | $100.08
-0.8% | 1/22/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Neutral -> Neutral | $120.00 -> $120.00 | High | View details for Cantor Fitzgerald rating of Seagate Technology (NASDAQ:STX) on 1/22/2025 |
RARE Ultragenyx Pharmaceutical | $41.84
-1.8% | 1/22/2025 | Reiterated by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $118.00 -> $118.00 | Medium | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 1/22/2025 |
SMTI Sanara MedTech | $35.39
+5.0% | 1/22/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $44.00 -> $44.00 | High | View details for Cantor Fitzgerald rating of Sanara MedTech (NASDAQ:SMTI) on 1/22/2025 |
META Meta Platforms | $668.13
-2.3% | 1/22/2025 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $730.00 -> $720.00 | Low | View details for Cantor Fitzgerald rating of Meta Platforms (NASDAQ:META) on 1/22/2025 |
GOOGL Alphabet | $179.25
-0.2% | 1/22/2025 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $215.00 -> $210.00 | Medium | View details for Cantor Fitzgerald rating of Alphabet (NASDAQ:GOOGL) on 1/22/2025 |
KROS Keros Therapeutics | $10.79
-2.1% | 1/21/2025 | Downgraded by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Neutral | | Medium | View details for Cantor Fitzgerald rating of Keros Therapeutics (NASDAQ:KROS) on 1/21/2025 |
AMPX Amprius Technologies | $2.80
-6.8% | 1/21/2025 | Initiated by | Cantor Fitzgerald | Analyst Derek Soderberg | Overweight | $10.00 | High | View details for Cantor Fitzgerald rating of Amprius Technologies (NYSE:AMPX) on 1/21/2025 |
ZM Zoom Video Communications | $81.10
-1.7% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Hold | $87.00 | N/A | View details for Cantor Fitzgerald rating of Zoom Video Communications (NASDAQ:ZM) on 1/16/2025 |
TEAM Atlassian | $284.06
-0.7% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Hold | $264.00 | N/A | View details for Cantor Fitzgerald rating of Atlassian (NASDAQ:TEAM) on 1/16/2025 |
SNOW Snowflake | $170.78
-4.0% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Strong-Buy | $201.00 | N/A | View details for Cantor Fitzgerald rating of Snowflake (NYSE:SNOW) on 1/16/2025 |
PLTR Palantir Technologies | $90.68
-10.5% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Hold | $72.00 | N/A | View details for Cantor Fitzgerald rating of Palantir Technologies (NASDAQ:PLTR) on 1/16/2025 |
ORCL Oracle | $170.00
+1.3% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Strong-Buy | $214.00 | N/A | View details for Cantor Fitzgerald rating of Oracle (NYSE:ORCL) on 1/16/2025 |
NOW ServiceNow | $926.32
-1.3% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Strong-Buy | $1,332.00 | N/A | View details for Cantor Fitzgerald rating of ServiceNow (NYSE:NOW) on 1/16/2025 |
Watch This Robotics Demo Before March 17th (Ad) Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%...
Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… |
NICE NICE | $160.99
+3.6% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Hold | $176.00 | N/A | View details for Cantor Fitzgerald rating of NICE (NASDAQ:NICE) on 1/16/2025 |
MSFT Microsoft | $404.00
-1.0% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Strong-Buy | $509.00 | N/A | View details for Cantor Fitzgerald rating of Microsoft (NASDAQ:MSFT) on 1/16/2025 |
MNDY monday.com | $298.10
-0.8% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Strong-Buy | $292.00 | N/A | View details for Cantor Fitzgerald rating of monday.com (NASDAQ:MNDY) on 1/16/2025 |
MDB MongoDB | $267.10
-2.3% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Strong-Buy | $344.00 | N/A | View details for Cantor Fitzgerald rating of MongoDB (NASDAQ:MDB) on 1/16/2025 |
INFA Informatica | $19.30
+0.0% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Hold | $29.00 | N/A | View details for Cantor Fitzgerald rating of Informatica (NYSE:INFA) on 1/16/2025 |
ESTC Elastic | $104.92
-1.4% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Hold | $108.00 | N/A | View details for Cantor Fitzgerald rating of Elastic (NYSE:ESTC) on 1/16/2025 |
DT Dynatrace | $59.02
-1.4% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Hold | $58.00 | N/A | View details for Cantor Fitzgerald rating of Dynatrace (NYSE:DT) on 1/16/2025 |
DOCN DigitalOcean | $37.18
-5.4% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Hold | $39.00 | N/A | View details for Cantor Fitzgerald rating of DigitalOcean (NYSE:DOCN) on 1/16/2025 |
WDC Western Digital | $49.02
-28.7% | 1/17/2025 | Reiterated by | Cantor Fitzgerald | Analyst C J Muse | Overweight -> Overweight | $95.00 -> $95.00 | Medium | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 1/17/2025 |
UNH UnitedHealth Group | $461.09
-1.1% | 1/17/2025 | Reiterated by | Cantor Fitzgerald | Analyst Sarah James | Overweight -> Overweight | $700.00 -> $700.00 | Low | View details for Cantor Fitzgerald rating of UnitedHealth Group (NYSE:UNH) on 1/17/2025 |
PSNY Polestar Automotive Holding UK | $1.10
| 1/17/2025 | Reiterated by | Cantor Fitzgerald | Analyst Andres Sheppard | Overweight -> Neutral | | Medium | View details for Cantor Fitzgerald rating of Polestar Automotive Holding UK (NASDAQ:PSNY) on 1/17/2025 |
ZM Zoom Video Communications | $81.10
-1.7% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Neutral | $87.00 | High | View details for Cantor Fitzgerald rating of Zoom Video Communications (NASDAQ:ZM) on 1/17/2025 |
SNOW Snowflake | $170.78
-4.0% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Overweight | $201.00 | Low | View details for Cantor Fitzgerald rating of Snowflake (NYSE:SNOW) on 1/17/2025 |
NOW ServiceNow | $926.32
-1.3% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Overweight | $1,332.00 | Low | View details for Cantor Fitzgerald rating of ServiceNow (NYSE:NOW) on 1/17/2025 |
PLTR Palantir Technologies | $90.68
-10.5% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Neutral | $72.00 | Medium | View details for Cantor Fitzgerald rating of Palantir Technologies (NASDAQ:PLTR) on 1/17/2025 |
ORCL Oracle | $170.00
+1.3% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Overweight | $214.00 | Low | View details for Cantor Fitzgerald rating of Oracle (NYSE:ORCL) on 1/17/2025 |
NICE NICE | $160.99
+3.6% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Neutral | $176.00 | Medium | View details for Cantor Fitzgerald rating of NICE (NASDAQ:NICE) on 1/17/2025 |
MDB MongoDB | $267.10
-2.3% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Overweight | $344.00 | Low | View details for Cantor Fitzgerald rating of MongoDB (NASDAQ:MDB) on 1/17/2025 |
MNDY monday.com | $298.10
-0.8% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Overweight | $292.00 | Low | View details for Cantor Fitzgerald rating of monday.com (NASDAQ:MNDY) on 1/17/2025 |
MSFT Microsoft | $404.00
-1.0% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Overweight | $509.00 | Medium | View details for Cantor Fitzgerald rating of Microsoft (NASDAQ:MSFT) on 1/17/2025 |
INFA Informatica | $19.30
+0.0% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Neutral | $29.00 | Low | View details for Cantor Fitzgerald rating of Informatica (NYSE:INFA) on 1/17/2025 |
FIVN Five9 | $41.77
-0.8% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Overweight | $46.00 | High | View details for Cantor Fitzgerald rating of Five9 (NASDAQ:FIVN) on 1/17/2025 |
ESTC Elastic | $104.92
-1.4% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Neutral | $108.00 | Medium | View details for Cantor Fitzgerald rating of Elastic (NYSE:ESTC) on 1/17/2025 |
DT Dynatrace | $59.02
-1.4% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Neutral | $58.00 | Low | View details for Cantor Fitzgerald rating of Dynatrace (NYSE:DT) on 1/17/2025 |
DOCN DigitalOcean | $37.18
-5.4% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Neutral | $39.00 | High | View details for Cantor Fitzgerald rating of DigitalOcean (NYSE:DOCN) on 1/17/2025 |
DDOG Datadog | $117.51
-1.8% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Overweight | $180.00 | Low | View details for Cantor Fitzgerald rating of Datadog (NASDAQ:DDOG) on 1/17/2025 |
CVLT Commvault Systems | $169.81
-0.5% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Neutral | $159.00 | High | View details for Cantor Fitzgerald rating of Commvault Systems (NASDAQ:CVLT) on 1/17/2025 |
NET Cloudflare | $147.92
-2.7% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Fitzgerald | Neutral | $111.00 | Medium | View details for Cantor Fitzgerald rating of Cloudflare (NYSE:NET) on 1/17/2025 |
TEAM Atlassian | $284.06
-0.7% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Neutral | $264.00 | Medium | View details for Cantor Fitzgerald rating of Atlassian (NASDAQ:TEAM) on 1/17/2025 |
PRE Prenetics Global | $5.71
+7.1% | 1/16/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $9.00 -> $9.00 | High | View details for Cantor Fitzgerald rating of Prenetics Global (NASDAQ:PRE) on 1/16/2025 |
FOLD Amicus Therapeutics | $9.34
+1.6% | 1/15/2025 | Reiterated by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $21.00 -> $21.00 | Low | View details for Cantor Fitzgerald rating of Amicus Therapeutics (NASDAQ:FOLD) on 1/15/2025 |
APLD Applied Digital | $9.02
-15.3% | 1/15/2025 | Target Lowered by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $15.00 -> $14.00 | High | View details for Cantor Fitzgerald rating of Applied Digital (NASDAQ:APLD) on 1/15/2025 |
PTCT PTC Therapeutics | $50.02
-1.3% | 1/15/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $80.00 -> $76.00 | High | View details for Cantor Fitzgerald rating of PTC Therapeutics (NASDAQ:PTCT) on 1/15/2025 |
ITCI Intra-Cellular Therapies | $128.57
0.0% | 1/14/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Duncan | Hold -> Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Intra-Cellular Therapies (NASDAQ:ITCI) on 1/14/2025 |
ORIC ORIC Pharmaceuticals | $7.56
-1.6% | 1/14/2025 | Reiterated by | Cantor Fitzgerald | Analyst Prakhar Agrawal | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 1/14/2025 |
XGN Exagen | $3.60
+0.6% | 1/13/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $8.00 -> $8.00 | Low | View details for Cantor Fitzgerald rating of Exagen (NASDAQ:XGN) on 1/13/2025 |
IDYA IDEAYA Biosciences | $21.31
-2.5% | 1/13/2025 | Reiterated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight -> Overweight | | Low | View details for Cantor Fitzgerald rating of IDEAYA Biosciences (NASDAQ:IDYA) on 1/13/2025 |
ONTO Onto Innovation | $158.15
-0.8% | 1/13/2025 | Initiated by | Cantor Fitzgerald | Analyst M. Prisco | Overweight | $250.00 | High | View details for Cantor Fitzgerald rating of Onto Innovation (NYSE:ONTO) on 1/13/2025 |
NVMI Nova | $259.15
-3.6% | 1/13/2025 | Initiated by | Cantor Fitzgerald | Analyst M. Prisco | Overweight | $275.00 | Low | View details for Cantor Fitzgerald rating of Nova (NASDAQ:NVMI) on 1/13/2025 |
CAMT Camtek | $78.40
+2.6% | 1/13/2025 | Initiated by | Cantor Fitzgerald | Analyst M. Prisco | Neutral | $100.00 | Medium | View details for Cantor Fitzgerald rating of Camtek (NASDAQ:CAMT) on 1/13/2025 |
INCY Incyte | $74.01
+2.6% | 1/10/2025 | Reiterated by | Cantor Fitzgerald | Analyst Eric Schmidt | Neutral -> Neutral | | Medium | View details for Cantor Fitzgerald rating of Incyte (NASDAQ:INCY) on 1/10/2025 |
VYGR Voyager Therapeutics | $4.10
-2.8% | 1/10/2025 | Initiated by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | $5.73 | High | View details for Cantor Fitzgerald rating of Voyager Therapeutics (NASDAQ:VYGR) on 1/10/2025 |
TVTX Travere Therapeutics | $21.23
-3.4% | 1/10/2025 | Initiated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | | Low | View details for Cantor Fitzgerald rating of Travere Therapeutics (NASDAQ:TVTX) on 1/10/2025 |
DRUG Bright Minds Biosciences | $35.94
-0.1% | 1/10/2025 | Initiated by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | | High | View details for Cantor Fitzgerald rating of Bright Minds Biosciences (NASDAQ:DRUG) on 1/10/2025 |
VRNS Varonis Systems | $42.90
-0.2% | 1/9/2025 | Initiated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Varonis Systems (NASDAQ:VRNS) on 1/9/2025 |
CHKP Check Point Software Technologies | $215.21
-0.7% | 1/9/2025 | Initiated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral | $200.00 | Low | View details for Cantor Fitzgerald rating of Check Point Software Technologies (NASDAQ:CHKP) on 1/9/2025 |
S SentinelOne | $21.90
-1.0% | 1/9/2025 | Initiated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight | $30.00 | Low | View details for Cantor Fitzgerald rating of SentinelOne (NYSE:S) on 1/9/2025 |
ZVRA Zevra Therapeutics | $7.45
-3.0% | 1/8/2025 | Initiated by | Cantor Fitzgerald | - | Overweight | $25.00 | Low | View details for Cantor Fitzgerald rating of Zevra Therapeutics (NASDAQ:ZVRA) on 1/8/2025 |
SABR Sabre | $4.29
-5.1% | 1/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Neutral | $5.00 -> $4.00 | High | View details for Cantor Fitzgerald rating of Sabre (NASDAQ:SABR) on 1/7/2025 |
HUT Hut 8 | $16.60
-7.4% | 1/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $35.00 -> $35.00 | High | View details for Cantor Fitzgerald rating of Hut 8 (NASDAQ:HUT) on 1/7/2025 |
Nvidia > DeepSeek (Ad) Everyone's getting it all wrong …
Sure, DeepSeek's reveal caused AI stocks to tumble …
But, in the long run … that's a good thing. Click here to see why Nvidia's bad day could end up being a great year. |
LCID Lucid Group | $2.78
-9.2% | 1/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Neutral | $3.00 -> $3.00 | High | View details for Cantor Fitzgerald rating of Lucid Group (NASDAQ:LCID) on 1/7/2025 |
AVR Anteris Technologies Global | $7.27
-11.9% | 1/7/2025 | Initiated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight | $9.00 | High | View details for Cantor Fitzgerald rating of Anteris Technologies Global (NASDAQ:AVR) on 1/7/2025 |
CIFR Cipher Mining | $4.97
-9.5% | 1/7/2025 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $11.00 -> $11.00 | High | View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 1/7/2025 |
WULF TeraWulf | $3.95
-3.2% | 1/6/2025 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $11.00 -> $11.00 | N/A | View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 1/6/2025 |
RIVN Rivian Automotive | $11.96
-7.8% | 1/6/2025 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 -> $13.00 | N/A | View details for Cantor Fitzgerald rating of Rivian Automotive (NASDAQ:RIVN) on 1/6/2025 |
ATYR Atyr PHARMA | $3.83
-11.3% | 1/6/2025 | Initiated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | | N/A | View details for Cantor Fitzgerald rating of Atyr PHARMA (NASDAQ:ATYR) on 1/6/2025 |
SUPN Supernus Pharmaceuticals | $32.68
-1.1% | 1/6/2025 | Initiated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $57.00 | N/A | View details for Cantor Fitzgerald rating of Supernus Pharmaceuticals (NASDAQ:SUPN) on 1/6/2025 |
CLDX Celldex Therapeutics | $21.33
-5.0% | 1/2/2025 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $67.00 -> $67.00 | N/A | View details for Cantor Fitzgerald rating of Celldex Therapeutics (NASDAQ:CLDX) on 1/2/2025 |
ETNB 89bio | $10.13
-8.4% | 1/2/2025 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $29.00 -> $29.00 | N/A | View details for Cantor Fitzgerald rating of 89bio (NASDAQ:ETNB) on 1/2/2025 |
RCEL AVITA Medical | $9.41
-3.5% | 12/24/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $21.00 -> $21.00 | N/A | View details for Cantor Fitzgerald rating of AVITA Medical (NASDAQ:RCEL) on 12/24/2024 |
CGNX Cognex | $32.84
+0.2% | 12/20/2024 | Upgraded by | Cantor Fitzgerald | Analyst T. Jensen | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of Cognex (NASDAQ:CGNX) on 12/20/2024 |
MPAA Motorcar Parts of America | $10.37
-0.7% | 12/20/2024 | Initiated by | Cantor Fitzgerald | Analyst D. Soderberg | Overweight | $14.00 | N/A | View details for Cantor Fitzgerald rating of Motorcar Parts of America (NASDAQ:MPAA) on 12/20/2024 |
APLD Applied Digital | $9.02
-15.3% | 12/20/2024 | Initiated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight | $15.00 | N/A | View details for Cantor Fitzgerald rating of Applied Digital (NASDAQ:APLD) on 12/20/2024 |
CGNX Cognex | $32.84
+0.2% | 12/19/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $49.00 | N/A | View details for Cantor Fitzgerald rating of Cognex (NASDAQ:CGNX) on 12/19/2024 |
MU Micron Technology | $95.41
-3.5% | 12/19/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $150.00 -> $130.00 | N/A | View details for Cantor Fitzgerald rating of Micron Technology (NASDAQ:MU) on 12/19/2024 |
PACK Ranpak | $7.06
0.0% | 12/19/2024 | Initiated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight | $11.50 | N/A | View details for Cantor Fitzgerald rating of Ranpak (NYSE:PACK) on 12/19/2024 |
UBER Uber Technologies | $76.34
-3.2% | 12/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $90.00 -> $90.00 | N/A | View details for Cantor Fitzgerald rating of Uber Technologies (NYSE:UBER) on 12/18/2024 |
AGIO Agios Pharmaceuticals | $35.47
+0.7% | 12/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Agios Pharmaceuticals (NASDAQ:AGIO) on 12/18/2024 |
ALXO ALX Oncology | $1.07
-4.5% | 12/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of ALX Oncology (NASDAQ:ALXO) on 12/18/2024 |
PVLA Palvella Therapeutics | $19.99
+4.0% | 12/18/2024 | Initiated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight | | N/A | View details for Cantor Fitzgerald rating of Palvella Therapeutics (NASDAQ:PVLA) on 12/18/2024 |
ACHR Archer Aviation | $8.39
-8.2% | 12/18/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $13.00 | N/A | View details for Cantor Fitzgerald rating of Archer Aviation (NYSE:ACHR) on 12/18/2024 |
IDYA IDEAYA Biosciences | $21.31
-2.5% | 12/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of IDEAYA Biosciences (NASDAQ:IDYA) on 12/17/2024 |
BHVN Biohaven | $35.46
-3.9% | 12/17/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 12/17/2024 |
TLSI TriSalus Life Sciences | $5.51
-4.5% | 12/17/2024 | Initiated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight | $10.00 | N/A | View details for Cantor Fitzgerald rating of TriSalus Life Sciences (NASDAQ:TLSI) on 12/17/2024 |
ESPR Esperion Therapeutics | $1.82
| 12/17/2024 | Initiated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $8.00 | N/A | View details for Cantor Fitzgerald rating of Esperion Therapeutics (NASDAQ:ESPR) on 12/17/2024 |
AQST Aquestive Therapeutics | $2.96
-1.7% | 12/17/2024 | Initiated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $17.00 | N/A | View details for Cantor Fitzgerald rating of Aquestive Therapeutics (NASDAQ:AQST) on 12/17/2024 |
ARCT Arcturus Therapeutics | $16.69
-6.1% | 12/16/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Arcturus Therapeutics (NASDAQ:ARCT) on 12/16/2024 |
AXSM Axsome Therapeutics | $130.72
-5.1% | 12/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $121.00 -> $121.00 | N/A | View details for Cantor Fitzgerald rating of Axsome Therapeutics (NASDAQ:AXSM) on 12/12/2024 |
BMRN BioMarin Pharmaceutical | $69.00
+1.1% | 12/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $90.00 -> $90.00 | N/A | View details for Cantor Fitzgerald rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 12/12/2024 |
GILD Gilead Sciences | $111.03
+1.0% | 12/11/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $80.00 -> $80.00 | N/A | View details for Cantor Fitzgerald rating of Gilead Sciences (NASDAQ:GILD) on 12/11/2024 |
CNC Centene | $58.89
+2.1% | 12/11/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $90.00 -> $90.00 | N/A | View details for Cantor Fitzgerald rating of Centene (NYSE:CNC) on 12/11/2024 |
ZURA Zura Bio | $1.33
-5.0% | 12/11/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Zura Bio (NASDAQ:ZURA) on 12/11/2024 |
TRML Tourmaline Bio | $12.25
+0.3% | 12/11/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | $25.00 -> $25.00 | N/A | View details for Cantor Fitzgerald rating of Tourmaline Bio (NASDAQ:TRML) on 12/11/2024 |
JANX Janux Therapeutics | $33.58
-6.7% | 12/11/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $200.00 -> $200.00 | N/A | View details for Cantor Fitzgerald rating of Janux Therapeutics (NASDAQ:JANX) on 12/11/2024 |
BEAM Beam Therapeutics | $30.79
+1.2% | 12/10/2024 | Upgraded by | Cantor Fitzgerald | Analyst R. Bienkowski | Hold | | N/A | View details for Cantor Fitzgerald rating of Beam Therapeutics (NASDAQ:BEAM) on 12/10/2024 |
QURE uniQure | $11.48
-10.6% | 12/10/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $28.00 -> $58.00 | N/A | View details for Cantor Fitzgerald rating of uniQure (NASDAQ:QURE) on 12/10/2024 |
RIGL Rigel Pharmaceuticals | $21.39
+6.5% | 12/10/2024 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $15.00 -> $25.00 | N/A | View details for Cantor Fitzgerald rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 12/10/2024 |
STOK Stoke Therapeutics | $8.50
+2.0% | 12/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Stoke Therapeutics (NASDAQ:STOK) on 12/10/2024 |
TSLA Tesla | $330.53
-2.2% | 12/10/2024 | Target Raised by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Neutral | $255.00 -> $365.00 | N/A | View details for Cantor Fitzgerald rating of Tesla (NASDAQ:TSLA) on 12/10/2024 |
ACHC Acadia Healthcare | $40.67
+2.6% | 12/10/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $52.00 -> $52.00 | N/A | View details for Cantor Fitzgerald rating of Acadia Healthcare (NASDAQ:ACHC) on 12/10/2024 |
AUR Aurora Innovation | $7.01
-5.7% | 12/10/2024 | Initiated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight | $10.00 | N/A | View details for Cantor Fitzgerald rating of Aurora Innovation (NASDAQ:AUR) on 12/10/2024 |
HUT Hut 8 | C$23.65
-7.3% | 12/9/2024 | Upgraded by | Cantor Fitzgerald | Analyst B. Knoblauch | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of Hut 8 (TSE:HUT) on 12/9/2024 |
MREO Mereo BioPharma Group | $2.69
-5.6% | 12/8/2024 | Upgraded by | Cantor Fitzgerald | Analyst K. Kluska | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of Mereo BioPharma Group (NASDAQ:MREO) on 12/8/2024 |
KALV KalVista Pharmaceuticals | $10.35
+3.2% | 12/9/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Stavropoulos | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of KalVista Pharmaceuticals (NASDAQ:KALV) on 12/9/2024 |
KURA Kura Oncology | $7.88
-4.5% | 12/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Kura Oncology (NASDAQ:KURA) on 12/9/2024 |
LEGN Legend Biotech | $36.98
-6.9% | 12/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $83.00 -> $83.00 | N/A | View details for Cantor Fitzgerald rating of Legend Biotech (NASDAQ:LEGN) on 12/9/2024 |
HUT Hut 8 | $16.60
-7.4% | 12/9/2024 | Initiated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $35.00 -> $35.00 | N/A | View details for Cantor Fitzgerald rating of Hut 8 (NASDAQ:HUT) on 12/9/2024 |
NNOX Nano-X Imaging | $6.02
-4.4% | 12/6/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $11.00 -> $12.00 | N/A | View details for Cantor Fitzgerald rating of Nano-X Imaging (NASDAQ:NNOX) on 12/6/2024 |
GTLB GitLab | $62.28
-2.9% | 12/6/2024 | Target Raised by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $75.00 -> $80.00 | N/A | View details for Cantor Fitzgerald rating of GitLab (NASDAQ:GTLB) on 12/6/2024 |
RBRK Rubrik | $67.63
-3.0% | 12/6/2024 | Target Raised by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $58.00 -> $70.00 | N/A | View details for Cantor Fitzgerald rating of Rubrik (NYSE:RBRK) on 12/6/2024 |
CXM Sprinklr | $8.73
-1.6% | 12/5/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Neutral -> Neutral | $9.00 -> $9.00 | N/A | View details for Cantor Fitzgerald rating of Sprinklr (NYSE:CXM) on 12/5/2024 |
COUR Coursera | $8.08
+0.6% | 12/5/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $10.00 -> $10.00 | N/A | View details for Cantor Fitzgerald rating of Coursera (NYSE:COUR) on 12/5/2024 |
RZLV Rezolve AI | $2.43
-4.7% | 12/5/2024 | Initiated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight | $5.00 | N/A | View details for Cantor Fitzgerald rating of Rezolve AI (NASDAQ:RZLV) on 12/5/2024 |
TNGX Tango Therapeutics | $2.35
-0.4% | 12/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Tango Therapeutics (NASDAQ:TNGX) on 12/5/2024 |
WULF TeraWulf | $3.95
-3.2% | 12/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $11.00 -> $11.00 | N/A | View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 12/4/2024 |
PRE Prenetics Global | $5.71
+7.1% | 12/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $9.00 -> $9.00 | N/A | View details for Cantor Fitzgerald rating of Prenetics Global (NASDAQ:PRE) on 12/4/2024 |
MRVL Marvell Technology | $97.91
-5.7% | 12/4/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $120.00 -> $135.00 | N/A | View details for Cantor Fitzgerald rating of Marvell Technology (NASDAQ:MRVL) on 12/4/2024 |
RNAC Cartesian Therapeutics | $19.02
-1.1% | 12/2/2024 | Upgraded by | Cantor Fitzgerald | Analyst K. Kluska | Hold | | N/A | View details for Cantor Fitzgerald rating of Cartesian Therapeutics (NASDAQ:RNAC) on 12/2/2024 |
IREN Iris Energy | $10.16
-6.6% | 11/27/2024 | Target Raised by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $20.00 -> $23.00 | N/A | View details for Cantor Fitzgerald rating of Iris Energy (NASDAQ:IREN) on 11/27/2024 |
NNOX Nano-X Imaging | $6.02
-4.4% | 11/26/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 -> $11.00 | N/A | View details for Cantor Fitzgerald rating of Nano-X Imaging (NASDAQ:NNOX) on 11/26/2024 |
